Scienmag

AUGUST 12, 2020

12) — Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the condition’s genetic foundations. The findings suggest that genetic analysis could be used to counsel parents who have previously experienced stillbirth and to unlock new human biology.

Genetics 40

Genetics Genetic Analysis Gene Research 40

The Pharma Data

SEPTEMBER 3, 2020

Our new study offers an important basis from which to start developing new treatment strategies for a rare form of cancer, which starts in the hormone-producing cells of the pancreas,” noted Dr Anguraj Sadanandam, team leader in Systems and Precision Cancer Medicine at The ICR, London. “We

Research 52

Research Genetic Analysis Gene Scientist 52

Delveinsight

FEBRUARY 25, 2021

Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing.

DNA 52

DNA In-Vivo Genetics Medicine 52

The Pharma Data

DECEMBER 11, 2020

“There is significant work to be done and sizable gaps to bridge,” said Dr. Chancellor Donald, assistant professor of medicine, hematology and medical oncology at Tulane University School of Medicine in New Orleans, who led the briefing.

Genetics 52

Genetics Clinical Trials Clinical Trials Genetic Analysis 52

The Pharma Data

JANUARY 7, 2021

. “The potential utility of this is that it can be used to define men who are at elevated risk of developing prostate cancer,” said lead author Christopher Haiman, professor of preventive medicine at Keck School of Medicine at the University of Southern California (USC) in Los Angeles.

Gene 52

Gene Genetics Genome Genomics 52

Drug Discovery World

MARCH 2, 2023

Advances in genetic analysis is currently allowing greater understanding of the diseases and potential therapeutic approaches, and it is an exciting area to work in in due to the current unmet need and advances can go on to inform treatment of other cancers.

Trials 52

Trials Development Genetic Analysis Drugs 52

pharmaphorum

NOVEMBER 16, 2022

So, pegcetacoplan blocks an inflammatory pathway that appears to be central for geopathic genesis based on extensive genetic analysis,” Dr Wykoff concluded. “AMD is the most common cause of blindness by far, in the US, in Europe, in many parts around the world,” Dr Wykoff said. About the interviewee. Dr Charles C.

Genetics 103

Genetics Trials Clinical Trials Clinical Trials 103

Drug Discovery World

FEBRUARY 28, 2023

Genetic analysis tools such as Sanger sequencing by Capillary Electrophoresis (CE) and qPCR are an integral part of the vector construction process to confirm and validate that the correct sequence of the gene is inserted into the vector backbone. She is passionate about advancing research in the pursuit of healthier lives for all.

Genetics 52

Genetics Genetic Analysis Vaccination Vaccine 52

pharmaphorum

APRIL 5, 2022

Genetic analysis of tumours can reveal mutations that are fuelling cancers growth, some of which can be targeted with treatment, they note. However, genomics alone is not able to reliably select drug combinations, and layering in their proteomics approach can improve the predictive power of this approach.

Protein 67

Protein Genetic Analysis Genome Genomics 67

XTalks

DECEMBER 1, 2020

Over the past several years, personalized medicine has led the charge in medical innovation, leading drug development efforts as well as furthering the research community’s understanding of human disease states.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

Drug Discovery World

APRIL 21, 2023

Managing all of these elements using iterative design and prototyping can play a key role in successful project delivery, and marrying technologies with biochemical or cellular assays has the potential to bring disruptive change across fields as diverse as personalised medicine, diagnostics and drug screening.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

Drug Discovery World

JUNE 14, 2023

Besides looking at donor characteristics, our platform, which we call Excellos 360TM, includes the assessment of metabolic and effector potential of cells, and genetic analysis. According to the spokesperson, blood donorship is hugely important for the development of new and potentially transformative macrophage cell therapies.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52